Characterization of the novel suramin analogue NF110 as a potent P2X3 receptor-selective antagonist

被引：0
|
作者：
Hausmann, R
Rettinger, J
Kassack, M
Lambrecht, G
Schmalzing, G
机构：
[1] Rhein Westfal TH Aachen, D-52074 Aachen, Germany
[2] Max Planck Inst Biophys, D-60439 Frankfurt, Germany
[3] Univ Bonn, Dept Pharmaceut Chem, D-53121 Bonn, Germany
[4] Univ Frankfurt, Dept Pharmacol, D-60439 Frankfurt, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2004年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
111
引用
收藏
页码：R28 / R28
页数：1
相关论文
共 50 条
  • [41] A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain
    Matsumura, Yuta
    Yamashita, Tomohiro
    Sasaki, Atsushi
    Nakata, Eriko
    Kohno, Keita
    Masuda, Takahiro
    Tozaki-Saitoh, Hidetoshi
    Imai, Toshiyasu
    Kuraishi, Yasushi
    Tsuda, Makoto
    Inoue, Kazuhide
    SCIENTIFIC REPORTS, 2016, 6
  • [42] A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats
    Wu, G
    Whiteside, GT
    Lee, G
    Nolan, S
    Niosi, M
    Pearson, MS
    Ilyin, VI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 504 (1-2) : 45 - 53
  • [43] Discovery of MK-2548: A P2X3 receptor antagonist for the treatment of chronic pain
    Paone, Daniel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [44] Selectivity of the P2X3 receptor antagonist Eliapixant, and its potential use in the treatment of endometriosis
    Fletcher, Michelle C.
    PURINERGIC SIGNALLING, 2022, 18 (01) : 1 - 3
  • [45] Selectivity of the P2X3 receptor antagonist Eliapixant, and its potential use in the treatment of endometriosis
    Michelle C. Fletcher
    Purinergic Signalling, 2022, 18 : 1 - 3
  • [46] Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists
    Lambertucci, Catia
    Sundukova, Mayya
    Kachare, Dhuldeo D.
    Panmand, Deepak S.
    Dal Ben, Diego
    Buccioni, Michela
    Marucci, Gabriella
    Marchenkova, Anna
    Thomas, Ajiroghene
    Nistri, Andrea
    Cristalli, Gloria
    Volpini, Rosaria
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 65 : 41 - 50
  • [47] In vitro characterization of a novel, potent and selective M-3 antagonist
    Ghelardini, C
    Bartolini, A
    Galeotti, N
    Bellucci, C
    Dei, S
    Gualtieri, F
    LIFE SCIENCES, 1997, 61 (13) : 1217 - 1226
  • [48] Regulation of the P2X2/P2X3 receptor by substance P
    Paukert, M
    Osterroth, R
    Brändle, U
    Glowatzki, E
    Gründer, S
    Ruppersberg, JP
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 457 - 457
  • [49] BLU-5937, A Potent and Selective P2X3 Antagonist, For the Treatment of Chronic Itch: Evidence from Pre-Clinical Studies
    Chauret, N.
    Ase, A. R.
    Seguela, P.
    Liu, X. Y.
    Matzouranis, T.
    Garceau, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S232 - S232
  • [50] Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors
    Virginio, C
    Robertson, G
    Surprenant, A
    North, RA
    MOLECULAR PHARMACOLOGY, 1998, 53 (06) : 969 - 973
12345